1440-1843/asset/RESP_left.gif?v=1&s=a110bec2019e1353a37e9b3af15908c01a36bc31)
1440-1843/asset/RESP_right.gif?v=1&s=2996c5a131272e16b9e97c7ece43b33e2548b8e2)
Adjuvant therapy with steroids or immunoglobulins
Article first published online: 19 OCT 2009
DOI: 10.1111/j.1440-1843.2009.01579.x
© 2009 The Japanese Respiratory Society. Journal compilation © 2009 Asian Pacific Society of Respirology
Issue
Respirology
Special Issue: The Japanese Respiratory Society Guidelines for the Management of Hospital-Acquired Pneumonia in Adults
Volume 14, Issue Supplement s2, pages S65–S67, November 2009
Additional Information
How to Cite
(2009), Adjuvant therapy with steroids or immunoglobulins. Respirology, 14: S65–S67. doi: 10.1111/j.1440-1843.2009.01579.x
Publication History
- Issue published online: 19 OCT 2009
- Article first published online: 19 OCT 2009
- Abstract
- Article
- References
- Cited By
SUMMARY
• Chemotherapy with antimicrobials is the basic treatment for pneumonia.
• Compared with community-acquired pneumonia, more cases of hospital-acquired pneumonia develop serious complications with ALI/ARDS, disseminated intravascular coagulation (DIC) or other conditions, and in many cases a number of drugs are used as adjuvant therapies.
• Adjuvant therapies include steroids, immunoglobulins, granulocyte-colony stimulating (G-CSF), blood purification and neutrophil elastase inhibitors.
• Little evidence has been accumulated in favour of these adjuvant therapies in pneumonia and their use is left to the discretion of the physician, but the indications should be considered carefully and general use avoided.